Market Access Fighting fake GLP-1s to protect patients & preserve trust Counterfeit drug promotion is a patient safety, brand equity, and public trust issue.
Sales & Marketing Ensuring product authenticity in the pharmaceutical industry... This year has seen a rapid rise in the demand for Ozempic due to it being popularised by celebrity endorsements online, leading to a shortage of product.
Views & Analysis Blockchain protocol: applications in healthcare System promises improvements in clinical trial verification and anti-counterfeiting.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
